Calcitriol and Pylera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcitriol (calcitriol) and Pylera (bismuth subcitrate potassium; metronidazole; tetracycline). Common drug interactions include chronic kidney disease among females.

The phase IV clinical study analyzes what interactions people have when they take Calcitriol and Pylera. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Calcitriol?

Calcitriol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 24,162 Calcitriol users. Check the latest studies of Calcitriol.

What is Pylera?

Pylera has active ingredients of bismuth subcitrate potassium; metronidazole; tetracycline. eHealthMe is studying from 1,036 Pylera users. Check the latest studies of Pylera.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 17, 2026

12 people who take Calcitriol and Pylera together, and have interactions are studied.

Calcitriol and Pylera drug interactions.

What are the common drug interactions of Calcitriol and Pylera, by gender? *:

female:

Chronic kidney disease
Chest pain
Renal failure (kidney dysfunction)
Cellulitis (infection under the skin)
Peptic ulcer
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Renal injury (kidney injury)
Small intestinal obstruction (blockage in small intestine)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)

male:

n/a

What are the common drug interactions of Calcitriol and Pylera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Chronic kidney disease
Cellulitis (infection under the skin)
Renal injury (kidney injury)
Chest pain
Peptic ulcer
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Small intestinal obstruction (blockage in small intestine)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)

What are the existing conditions these people have? *

Stress And Anxiety: 12 people, 100.00%
Pain: 12 people, 100.00%
High Blood Cholesterol: 8 people, 66.67%
Asthma: 8 people, 66.67%
Blood Calcium Decreased: 8 people, 66.67%
Blood Iron Decreased: 8 people, 66.67%
Blood Magnesium Decreased: 8 people, 66.67%
Diabetes: 8 people, 66.67%
Gastric Ulcer (stomach ulcer): 8 people, 66.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Calcitriol and Pylera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously